Security Snapshot

Concentrix Corp - COMMON STOCK (CNXC) Institutional Ownership

CUSIP: 20602D101

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

333

Shares (Excl. Options)

60,071,877

Price

$41.58

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COMMON STOCK
Symbol
CNXC on Nasdaq
Shares outstanding
61,206,982
Price per share
$28.50
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
60,071,877
Total reported value
$2,497,645,975
% of total 13F portfolios
0%
Share change
-1,513,443
Value change
-$88,972,682
Number of holders
333
Price from insider filings
$28.50
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CNXC - Concentrix Corp - COMMON STOCK is tracked under CUSIP 20602D101.
  • 333 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 333 to 138 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,497,645,975 to $731,886,949.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 333 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 20602D101?
CUSIP 20602D101 identifies CNXC - Concentrix Corp - COMMON STOCK in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Concentrix Corp - COMMON STOCK (CNXC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Synnex Technology International CORP 7.1% $119,548,836 4,369,475 Synnex Technology International CORP 31 Mar 2026
FMR LLC 6.9% +123% $120,363,530 +$61,583,883 4,223,282 +105% FMR LLC 31 Mar 2026
Impactive Capital LP 4.9% $141,505,730 3,066,213 Impactive Capital LP 05 Nov 2025
AQR CAPITAL MANAGEMENT LLC 4.7% -30% $129,458,594 -$59,465,386 2,950,287 -31% AQR Capital Management, LLC 31 Dec 2025
Groupe Bruxelles Lambert 4.6% -69% $79,049,510 -$171,000,000 2,773,667 -68% Groupe Bruxelles Lambert 29 Apr 2026

As of 31 Dec 2025, 333 institutional investors reported holding 60,071,877 shares of Concentrix Corp - COMMON STOCK (CNXC). This represents 98% of the company’s total 61,206,982 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Concentrix Corp - COMMON STOCK (CNXC) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Groupe Bruxelles Lambert 14% 8,773,667 0% 100% $364,809,074
VANGUARD GROUP INC 8.1% 4,932,539 -2.5% 0% $205,094,971
BlackRock, Inc. 6.3% 3,826,872 -0.87% 0% $159,121,325
AQR CAPITAL MANAGEMENT LLC 4.8% 2,950,287 -33% 0.06% $122,672,947
PZENA INVESTMENT MANAGEMENT LLC 4.8% 2,927,196 +32% 0.36% $121,712,810
FMR LLC 4.6% 2,809,039 -0.66% 0.01% $116,799,834
DIMENSIONAL FUND ADVISORS LP 4.1% 2,491,270 +28% 0.02% $103,587,651
FIL Ltd 4.1% 2,490,124 -1.2% 0.08% $103,539,356
1832 Asset Management L.P. 3.7% 2,273,038 +47% 0.12% $94,512,920
FULLER & THALER ASSET MANAGEMENT, INC. 3.3% 2,014,615 -9.7% 0.28% $83,767,691
STATE STREET CORP 2.4% 1,491,760 -4.4% 0% $62,027,381
LYRICAL ASSET MANAGEMENT LP 1.9% 1,191,702 -6.8% 0.7% $49,550,969
MORGAN STANLEY 1.8% 1,098,147 +22% 0% $45,660,988
Copeland Capital Management, LLC 1.8% 1,088,922 -10% 1% $45,277,488
PRUDENTIAL FINANCIAL INC 1.5% 937,635 +191% 0.05% $38,986,863
GEODE CAPITAL MANAGEMENT, LLC 1.4% 879,541 -5.6% 0% $36,579,534
Invenomic Capital Management LP 1.4% 874,241 +6.3% 1.8% $36,350,941
FIRST TRUST ADVISORS LP 1.3% 805,898 +38% 0.02% $33,509,336
Bank of New York Mellon Corp 1.2% 709,770 +157% 0.01% $29,512,239
Boston Partners 0.93% 568,150 -8.7% 0.02% $23,409,963
Alyeska Investment Group, L.P. 0.9% 551,058 0.06% $22,912,992
CAPITAL MANAGEMENT CORP /VA 0.84% 511,736 +8.3% 3.5% $21,277,988
LOOMIS SAYLES & CO L P 0.82% 500,341 +0.91% 0.03% $20,804,169
Invesco Ltd. 0.78% 478,790 +16% 0% $19,908,087
D. E. Shaw & Co., Inc. 0.78% 478,632 +367% 0.02% $19,901,518

Institutional Holders of Concentrix Corp - COMMON STOCK (CNXC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 26,750,382 $731,886,949 +$63,315,938 $27.36 138
2025 Q4 60,071,877 $2,497,645,975 -$88,972,682 $41.58 333
2025 Q3 61,863,171 $2,855,770,411 +$87,822,733 $46.15 343
2025 Q2 59,833,745 $3,158,719,934 +$49,202,867 $52.86 332
2025 Q1 58,776,624 $3,269,414,256 +$98,385,834 $55.64 342
2024 Q4 57,223,103 $2,476,651,188 +$125,226,031 $43.27 289
2024 Q3 53,990,013 $2,766,736,840 +$83,873,236 $51.25 282
2024 Q2 52,196,409 $3,303,445,630 +$37,847,790 $63.28 296
2024 Q1 51,544,214 $3,411,172,549 -$61,671,340 $66.22 289
2023 Q4 51,918,056 $5,098,838,795 -$632,029,890 $98.21 307
2023 Q3 51,502,925 $4,125,685,875 +$790,491,893 $80.11 298
2023 Q2 41,538,922 $3,354,573,894 +$44,407,699 $80.75 309
2023 Q1 40,569,310 $4,931,164,976 +$54,913,139 $121.55 318
2022 Q4 40,098,524 $5,325,090,511 -$7,546,571 $133.16 316
2022 Q3 40,151,797 $4,482,825,617 -$86,241,795 $111.63 299
2022 Q2 40,745,194 $5,526,062,407 +$45,635,823 $135.64 310
2022 Q1 40,170,835 $6,688,310,260 +$81,227,033 $166.56 342
2021 Q4 39,731,695 $7,095,615,619 -$84,004,727 $178.62 336
2021 Q3 39,869,063 $7,057,113,556 -$15,440,556 $177.00 312
2021 Q2 39,956,632 $6,427,157,794 +$165,407,388 $160.80 310
2021 Q1 38,970,679 $5,835,856,967 +$145,609,050 $149.72 309
2020 Q4 38,167,327 $3,767,009,801 +$3,760,978,801 $98.70 282
2020 Q3 75 $12,000 $160.00 1
2020 Q2 75 $12,000 $160.00 1
2020 Q1 75 $12,000 $160.00 1
2019 Q4 75 $12,000 $160.00 1
2019 Q3 75 $12,000 $160.00 1
2019 Q2 75 $12,000 $160.00 1
2019 Q1 75 $12,000 $160.00 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .